A recent genomic sequencing study that combined large-scale tumor exome analysis with MHC I class prediction revealed a strong positive correlation between IDO1 expression, mutational burden, and neoantigen load in cervical cancers (36). This evidence concerns the gene IDO1 and cervical cancer.